Literature DB >> 30888515

TRPM2 mediates distruption of autophagy machinery and correlates with the grade level in prostate cancer.

Ahmet Tektemur1, Seda Ozaydin2, Ebru Etem Onalan2, Nalan Kaya3, Tuncay Kuloglu3, İbrahim Hanifi Ozercan4, Suat Tekin5, Halit Mohammed Elyas2.   

Abstract

PURPOSE: Transient receptor potential melastatin 2 (TRPM2), a calcium-permeable ion channel, is shown as a prognostic marker candidate in prostate cancer (PCa) and an important regulator of autophagy. We aimed to determine the changes in TRPM2 and autophagic-apoptotic gene expression levels in human prostate adenocarcinomas, and to investigate the affect of TRPM2 on autophagic pathways in PC-3 cell line.
METHODS: Human prostate tissues were classified considering the grade levels and were divided into the control, BPH, and grade 1-5 groups. mRNA expression levels of genes were determined by qPCR. In addition, TRPM2 was evaluated immunohistochemically for each group. In PC-3 cell line, TRPM2 was silenced through siRNA transfection, and autophagy induction was analyzed by acridine orange (AO) staining.
RESULTS: The qPCR and immunoreactivity results showed that the increased TRPM2 expression levels in human PCa samples were paralleled with higher grade levels. The autophagic-apoptotic gene expressions showed high variability in different grade levels. Also, silencing TRPM2 in PC-3 cells altered autophagic gene expressions and caused autophagy induction according to the AO staining results.
CONCLUSION: We showed that the autophagy-TRPM2 association may take place in the molecular basis of PCa and accordingly this connection may be targeted as a new therapeutic approach in PCa.

Entities:  

Keywords:  Autophagy; Gene expression; Ion channels; Prostate cancer; Transient receptor potential melastatin 2 (TRPM2)

Mesh:

Substances:

Year:  2019        PMID: 30888515     DOI: 10.1007/s00432-019-02898-z

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  5 in total

1.  Development and Validation of an Autophagy-Related Signature for Head and Neck Squamous Cell Carcinoma.

Authors:  Chang Liu; Wenling Wu; Meng Xu; Jinglin Mi; Longjiang Xu; Rensheng Wang
Journal:  Biomed Res Int       Date:  2021-08-11       Impact factor: 3.411

Review 2.  Role of Calcium Signaling in Prostate Cancer Progression: Effects on Cancer Hallmarks and Bone Metastatic Mechanisms.

Authors:  Juan A Ardura; Luis Álvarez-Carrión; Irene Gutiérrez-Rojas; Verónica Alonso
Journal:  Cancers (Basel)       Date:  2020-04-25       Impact factor: 6.639

Review 3.  Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response.

Authors:  Milad Ashrafizadeh; Mahshid Deldar Abad Paskeh; Sepideh Mirzaei; Mohammad Hossein Gholami; Ali Zarrabi; Farid Hashemi; Kiavash Hushmandi; Mehrdad Hashemi; Noushin Nabavi; Francesco Crea; Jun Ren; Daniel J Klionsky; Alan Prem Kumar; Yuzhuo Wang
Journal:  J Exp Clin Cancer Res       Date:  2022-03-22

4.  Identification of Calcium Channel-Related Gene P2RX2 for Prognosis and Immune Infiltration in Prostate Cancer.

Authors:  Qinyu Li; Bili Wu; Motuma Daba; Xintao Gao; Bingliang Chen; Guoda Song; Kai Zeng; Jianping Miao; Xianglin Yuan; Jihong Liu; Zhihua Wang; Bo Liu
Journal:  Dis Markers       Date:  2022-09-30       Impact factor: 3.464

5.  Development of an autophagy-related gene expression signature for prognosis prediction in prostate cancer patients.

Authors:  Daixing Hu; Li Jiang; Shengjun Luo; Xin Zhao; Hao Hu; Guozhi Zhao; Wei Tang
Journal:  J Transl Med       Date:  2020-04-07       Impact factor: 5.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.